-
-
-
-
-
-
-
Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary
-
-
-
-
-
-
-
ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases
-
-
-
-
-
-
-
Alumis and ACELYRIN Announce Amended Merger Agreement
-
-
-
-
-
-
-
Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger
-
-
-
-
-
-
-
Alumis (ALMS) Announces Leadership Changes
-
-
1,160,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

